ICSMA-19-029-02

Vulnerability from csaf_cisa - Published: 2019-01-29 00:00 - Updated: 2019-02-05 00:00
Summary
BD FACSLyric (Update A)

Notes

CISA Disclaimer
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
Legal Notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Risk evaluation
Successful exploitation of this vulnerability may allow an attacker to gain unauthorized access to administrative level privileges on a workstation, which could allow arbitrary execution of commands. This vulnerability does not impact BD FACSLyric flow cytometry systems using the Windows 7 Operating System.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
Worldwide
Company headquarters location
United States
Recommended Practices
NCCIC recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
Recommended Practices
NCCIC reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.NCCIC also provides a section for control systems security recommended practices on the ICS-CERT web page. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS-CERT website in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to NCCIC for tracking and correlation against other incidents.
Exploitability
No known public exploits specifically target this vulnerability. This vulnerability is not exploitable remotely.

{
  "document": {
    "acknowledgments": [
      {
        "names": [
          "BD"
        ],
        "summary": "reporting this vulnerability to NCCIC"
      }
    ],
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "general",
        "text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
        "title": "CISA Disclaimer"
      },
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "summary",
        "text": "Successful exploitation of this vulnerability may allow an attacker to gain unauthorized access to administrative level privileges on a workstation, which could allow arbitrary execution of commands. This vulnerability does not impact BD FACSLyric flow cytometry systems using the Windows 7 Operating System.",
        "title": "Risk evaluation"
      },
      {
        "category": "other",
        "text": "Healthcare and Public Health",
        "title": "Critical infrastructure sectors"
      },
      {
        "category": "other",
        "text": "Worldwide",
        "title": "Countries/areas deployed"
      },
      {
        "category": "other",
        "text": "United States",
        "title": "Company headquarters location"
      },
      {
        "category": "general",
        "text": "NCCIC recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "NCCIC reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.NCCIC also provides a section for control systems security recommended practices on the ICS-CERT web page. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS-CERT website in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to NCCIC for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "other",
        "text": "No known public exploits specifically target this vulnerability. This vulnerability is not exploitable remotely.",
        "title": "Exploitability"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-19-029-02 JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2019/icsma-19-029-02.json"
      },
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-19-029-02 Web Version",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-029-02"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-029-02"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B"
      }
    ],
    "title": "BD FACSLyric (Update A)",
    "tracking": {
      "current_release_date": "2019-02-05T00:00:00.000000Z",
      "generator": {
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-19-029-02",
      "initial_release_date": "2019-01-29T00:00:00.000000Z",
      "revision_history": [
        {
          "date": "2019-01-29T00:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "ICSMA-19-029-02 BD FACSLyric "
        },
        {
          "date": "2019-02-05T00:00:00.000000Z",
          "legacy_version": "A",
          "number": "2",
          "summary": "ICSMA-19-029-02 BD FACSLyric (Update A)"
        }
      ],
      "status": "final",
      "version": "2"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version",
                "name": "Windows 10 Professional Operating System U.S. release",
                "product": {
                  "name": "FACSLyric: IVD Windows 10 Professional Operating System U.S. release",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "FACSLyric IVD"
          },
          {
            "branches": [
              {
                "category": "product_version",
                "name": "Windows 10 Professional Operating System, U.S. and Malaysian Releases, between November 2017 and November 2018",
                "product": {
                  "name": "FACSLyric: Research Use Only Windows 10 Professional Operating System U.S. and Malaysian Releases between November 2017 and November 2018",
                  "product_id": "CSAFPID-0002"
                }
              }
            ],
            "category": "product_name",
            "name": "FACSLyric Research Use Only"
          }
        ],
        "category": "vendor",
        "name": "Becton, Dickinson and Company (BD)"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2019-6517",
      "cwe": {
        "id": "CWE-284",
        "name": "Improper Access Control"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The system does not properly enforce user access control to a privileged account, which may allow for unauthorized access to administrative level functions.CVE-2019-6517 has been assigned to this vulnerability. A CVSS v3 base score of 6.8 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2019-6517"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "BD will follow-up directly with all affected users to perform remediation activities. BD will disable the administrative account for users with BD FACSLyric RUO Cell Analyzer units having the Windows 10 Pro Operating System. BD has contacted and will replace the computer workstations for affected users with the BD FACSLyric IVD Cell Analyzer units with the Windows 10 Pro Operating System.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For additional information regarding the reported vulnerability please contact BD for the following support:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For technical support, please contact the BD Biosciences General Tech Support - Flow Cytometry via email researchapplications@bd.com or phone 877-232-8995 Option 2 and then Option 2 again.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For more information on BD \u0027s product security and vulnerability management, contact BD \u0027s Product Security Office:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "https://www.bd.com/productsecurity  ",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.bd.com/productsecurity"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 6.8,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        }
      ]
    }
  ]
}


Log in or create an account to share your comment.




Tags
Taxonomy of the tags.


Loading…

Loading…

Loading…

Sightings

Author Source Type Date

Nomenclature

  • Seen: The vulnerability was mentioned, discussed, or observed by the user.
  • Confirmed: The vulnerability has been validated from an analyst's perspective.
  • Published Proof of Concept: A public proof of concept is available for this vulnerability.
  • Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
  • Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
  • Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
  • Not confirmed: The user expressed doubt about the validity of the vulnerability.
  • Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.


Loading…

Detection rules are retrieved from Rulezet.

Loading…

Loading…